Bilim Pharmaceuticals
Bilim Pharmaceuticals is a 100% domestically owned Turkish generic-drug manufacturer founded in 1953, producing 480 licensed medicines across nine therapeutic areas from three FDA-standard facilities and serving physicians, pharmacists, and patients in Turkey and 70+ export markets.
- Company typePrivate
- Founded1953
- HeadquartersBeyoglu
- Headcount501–1,000
- GTM typeB2B and B2C
- OfferingHardware or Manufacturing
What Bilim Pharmaceuticals does
Bilim Pharmaceuticals (legal name: Bilim İlaç Sanayii ve Ticaret Anonim Şirketi) is a 100% domestically owned Turkish pharmaceutical manufacturer founded in 1953 and headquartered in Beyoğlu, İstanbul. The company develops, manufactures, and markets generic equivalents of patent-expired originator medicines across nine therapeutic areas — antibiotics, respiratory, musculoskeletal, ophthalmology, endocrinology/metabolism, gastroenterology, urogenital, cardiovascular, and dermatology — operating from a portfolio of 480 licensed medicines of which approximately 200 are actively marketed. Manufacturing is performed across three sites: a 2008-commissioned Gebze facility designed to FDA standards producing solid, liquid, and semi-solid dosage forms; a 1998 Çerkezköy penicillin facility; and a 2019 Sterile Liquid Products facility approved by the Turkish Ministry of Health for solution and suspension Nebul Inhaler products. A USD 15 million R&D center operates with FDA-standard pilot production, QbD methodology, CTD-format registration capabilities, and 100+ scientists across formulation, analytical development, and clinical research. The company holds GMP, GLP, ISO 14001, ISO 27001, KVKK, PCI DSS, and CMMC Level 1 certifications, and was ranked 2nd in box ranking among 753 companies in the Turkish pharmaceutical market (2022 data) and 1st in prescription preference in its operating markets.
Bilim's revenue model is concentrated on one-time product sales of licensed pharmaceuticals, primarily through a domestic field force of nearly 1,000 employees organized in 8 specialty teams across 11 regions covering all 81 Turkish provinces. Customers are healthcare professionals (physicians across 14 specialties plus pharmacists) who dispense and prescribe the products to patients in Turkey's regulated pharmaceutical pricing environment. Internationally, the company exports through representative offices in Moldova (2007), Albania (2009), and UAE/Dubai (2022), supported by a global marketing team of approximately 300, with cumulative export revenue milestones progressing from USD 10 million (2006) to USD 55 million (2020) and over 1,200 product licenses in international markets. Bilim was recognized as the leading exporter among Turkish pharmaceutical companies in 2016 and operates contract manufacturing, technology-transfer, co-marketing, and joint-development agreements across 70+ countries. The firm maintains a group-company relationship with subsidiary Hüsnü Arsan İlaçları A.Ş. and supports an Orange Hour volunteer program that has touched nearly 80,000 people since 2005.
Bilim Pharmaceuticals firmographics
Firmographics- Name
- Bilim Pharmaceuticals
- Legal name
- Bilim İlaç Sanayii ve Ticaret Anonim Şirketi
- Website
- https://bilimilac.com.tr
- Company type
- Private
- Founded year
- 1953
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- Bilim Pharmaceuticals is a 100% domestically owned Turkish generic-drug manufacturer founded in 1953, producing 480 licensed medicines across nine therapeutic areas from three FDA-standard facilities and serving physicians, pharmacists, and patients in Turkey and 70+ export markets.
- Ownership category
- akta.pro rank
Bilim Pharmaceuticals industry classification
Industry- Product category
- Generic Pharmaceuticals
- NAICS
- Pharmaceutical Preparation Manufacturing (325412)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Generic Hospital & Institutional Products (HLAIABAL)
Keywords
Where Bilim Pharmaceuticals is headquartered
LocationHeadquarters
- HQ city
- Beyoglu
Offices17 records
Markets served
Bilim Pharmaceuticals business model
Business model- GTM type
- B2B and B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales
Revenue model
- Pharmaceutical Product Sales: Bilim Pharmaceuticals generates revenue through the sale of licensed pharmaceutical products. The company has 480 licensed medicines with approximately 200 products actively on the market, covering therapeutic areas including antibiotics, respiratory system, musculoskeletal system, ophthalmology, endocrinology, gastroenterology, urogenital system, cardiovascular system, and dermatology.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels4 records
Bilim Pharmaceuticals product offering
Product offeringCore offering
Bilim Pharmaceuticals manufactures, licenses, and markets a broad portfolio of branded generic and prescription medicines across multiple therapeutic areas, including antibiotics, respiratory, cardiovascular, musculoskeletal, ophthalmology, endocrinology, gastroenterology, urogenital, and dermatology. The company operates domestic manufacturing facilities and an in-house R&D center, and sells both in Turkey and through international exports.
Product overview
Bilim Pharmaceuticals is a 100% domestically-owned Turkish pharmaceutical company founded in 1953. It operates as a single unified product portfolio company offering 480 licensed medicines, with approximately 200 actively marketed products across Turkey. The company produces pharmaceutical products across multiple therapeutic areas including antibiotics, respiratory system medicines, musculoskeletal system products, ophthalmology, endocrinology, gastroenterology, urogenital system, cardiovascular system, and dermatology. The product portfolio is supported by FDA-standard R&D facilities and three production facilities (Gebze, Çerkezköy Penicillin, and Sterile Liquid), with the R&D center developing generic versions of patent-expired original medicines.
Differentiator
Problem solved
Functional benefit
Products and services
- Antibiotic pharmaceutical portfolio Branded generic and prescription antibacterial medicines produced primarily at the Çerkezköy penicillin facility, distributed to wholesalers, hospitals, and pharmacies in Turkey and export markets.
- Respiratory pharmaceutical portfolio Prescription and OTC respiratory medicines marketed to physicians, pharmacies, and hospitals across Turkey and selected export markets.
- Cardiovascular pharmaceutical portfolio Cardiovascular prescription drugs supplied to Turkish wholesalers, hospitals, and reimbursement systems, and exported through international partners.
- Sterile liquid pharmaceutical products Sterile liquid (injectable and liquid) dosage form pharmaceuticals manufactured at Bilim's sterile liquid facility, marketed across multiple therapeutic areas for hospital and retail channel use.
- Musculoskeletal, ophthalmology, endocrinology, gastroenterology, urogenital, and dermatology portfolios Prescription specialty pharmaceutical product lines spanning musculoskeletal, ophthalmology, endocrinology, gastroenterology, urogenital, and dermatology indications, sold through Turkish and international channels.
Quantifiable outcome
- Ranked 2nd in box ranking among 753 companies in Turkish pharmaceutical market (2022)
- +3 more outcomes
Companies that use Bilim Pharmaceuticals
Customer profileNamed customers2 records
Segments3 records
Ideal customer profiles2 records
Bilim Pharmaceuticals technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
Bilim Pharmaceuticals partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- International Distribution PartnerscoreContract manufacturing for regulated and non-regulated markets, technology transfer agreements, co-marketing agreements, and joint product development partnerships in 70+ countries. Over 1,200 product licenses in international markets with marketing team of 300 people globally.
- Hüsnü Arsan İlaçları A.Ş.coreHüsnü Arsan İlaçları A.Ş. is Bilim Pharmaceuticals' group company (topluluk şirketi). Both companies share pharmacovigilance activities and the company contact form covers products from both Bilim İlaç San ve Tic. A.Ş. and Hüsnü Arsan İlaçları A.Ş.
Scale indicators15 records
Recent moves7 records
Expansion highlights6 records
Bilim Pharmaceuticals competitors and assessment
Company assessmentDirect peers
- Sanovel Pharmaceuticals: Turkish generic manufacturer with broad multi-therapeutic portfolio and growing export presence; competes with Bilim domestically and in regional export markets.
- Hüsnü Arsan İlaçları: Bilim's group-affiliated Turkish pharmaceutical company sharing pharmacovigilance and certain operations; relevant as a directly comparable Turkish domestic pharma peer in same group structure.
- Nobel İlaç: Another leading Turkish generic pharmaceutical manufacturer with multi-category product portfolio and overseas expansion; competes head-to-head with Bilim in domestic market rankings.
- Abdi İbrahim: Turkey's largest domestic pharmaceutical company and Bilim's closest domestic competitor; both focus on generic drug manufacturing, broad therapeutic-area portfolios, and operate nationwide field sales organisations in Turkey.
- Eczacıbaşı (EIP): Major Turkish pharma group with branded generics across multiple therapeutic areas including respiratory and dermatology; overlaps with Bilim's product portfolio and Turkish distribution footprint.
Broad incumbents
- Stada Arzneimittel: European-based generics and specialty pharma company with strong presence in European and CIS markets that overlap with Bilim's regional export channels.
- Teva Pharmaceutical Industries: World's largest generic drug manufacturer with a broad specialty, generic, and biosimilar portfolio; directly comparable to Bilim in therapeutic-area breadth and international reach.
- Aurobindo Pharma: Large Indian generic manufacturer with vertically integrated API and finished-dose operations; competes with Bilim in international tenders and contract manufacturing markets.
- Sandoz (Novartis): Global generics leader producing prescription and specialty generics across all major therapeutic areas; competes with Bilim in Turkey and across Bilim's 70+ international markets.
- Viatris: Global generics and specialty company combining legacy Mylan and Upjohn; competes with Bilim on generic prescription drugs in Turkey and across its 70-country international footprint.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
Bilim Pharmaceuticals social profiles
Digital presenceBilim Pharmaceuticals compliance and trust
Trust signalCompliance9 records
Bilim Pharmaceuticals financial estimates
Financial estimateRevenue estimate
Valuation estimate
Bilim Pharmaceuticals leadership team
Management profileNumber of profiles
Bilim Pharmaceuticals subsidiaries and ownership
Company hierarchySubsidiaries1 record
Bilim Pharmaceuticals funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Bilim Pharmaceuticals M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Bilim Pharmaceuticals
What does Bilim Pharmaceuticals do?
Bilim Pharmaceuticals manufactures, licenses, and markets a broad portfolio of branded generic and prescription medicines across multiple therapeutic areas, including antibiotics, respiratory, cardiovascular, musculoskeletal, ophthalmology, endocrinology, gastroenterology, urogenital, and dermatology. The company operates domestic manufacturing facilities and an in-house R&D center, and sells both in Turkey and through international exports.
Is Bilim Pharmaceuticals a public or private company?
Bilim Pharmaceuticals is a private company. It is classified as family owned and is currently operating.
When was Bilim Pharmaceuticals founded?
Bilim Pharmaceuticals was founded in 1953. It employs 501 to 1,000 people.
Where is Bilim Pharmaceuticals based?
Bilim Pharmaceuticals is headquartered in Beyoglu.
How does Bilim Pharmaceuticals make money?
One revenue line is on record: pharmaceutical Product Sales.
Who are Bilim Pharmaceuticals's main competitors?
Direct peers on record are Sanovel Pharmaceuticals, Hüsnü Arsan İlaçları, Nobel İlaç, Abdi İbrahim and Eczacıbaşı (EIP). Broad incumbents are Stada Arzneimittel, Teva Pharmaceutical Industries, Aurobindo Pharma, Sandoz (Novartis) and Viatris.
Does Bilim Pharmaceuticals have an API?
No public API is recorded for Bilim Pharmaceuticals.
What industry is Bilim Pharmaceuticals in?
Bilim Pharmaceuticals's product category is Generic Pharmaceuticals. Its primary akta.pro industry code is HLAIABAL, Generic Hospital & Institutional Products. Its NAICS code is 325412 and its SIC code is 2834.